Follow
Dongqing Yan, Ph.D.
Dongqing Yan, Ph.D.
The University of Utah, Huntsman Cancer Institute
Verified email at hci.utah.edu
Title
Cited by
Cited by
Year
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease
H Akada, D Yan, H Zou, S Fiering, RE Hutchison, MG Mohi
Blood, The Journal of the American Society of Hematology 115 (17), 3589-3597, 2010
2812010
Combining the allosteric inhibitor asciminib with ponatinib suppresses emergence of and restores efficacy against highly resistant BCR-ABL1 mutants
CA Eide, MS Zabriskie, SLS Stevens, O Antelope, NA Vellore, H Than, ...
Cancer Cell 36 (4), 431-443. e5, 2019
1682019
Characterization of a DRE-binding transcription factor from a halophyte Atriplex hortensis
YG Shen, WK Zhang, DQ Yan, BX Du, JS Zhang, Q Liu, SY Chen
Theoretical and Applied Genetics 107, 155-161, 2003
1642003
Age-related mutations and chronic myelomonocytic leukemia
CC Mason, JS Khorashad, SK Tantravahi, TW Kelley, MS Zabriskie, ...
Leukemia 30 (4), 906-913, 2016
1432016
Critical requirement for Stat5 in a mouse model of polycythemia vera
D Yan, RE Hutchison, G Mohi
Blood, The Journal of the American Society of Hematology 119 (15), 3539-3549, 2012
1412012
A salt-responsive receptor-like kinase gene regulated by the ethylene signaling pathway encodes a plasma membrane serine/threonine kinase
XJ He, ZG Zhang, DQ Yan, JS Zhang, SY Chen
Theoretical and Applied Genetics 109, 377-383, 2004
942004
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
WL Heaton, AV Senina, AD Pomicter, ME Salama, PM Clair, D Yan, ...
Leukemia 32 (11), 2399-2411, 2018
472018
SIRT5 is a druggable metabolic vulnerability in acute myeloid leukemia
D Yan, A Franzini, AD Pomicter, BJ Halverson, O Antelope, CC Mason, ...
Blood cancer discovery 2 (3), 266-287, 2021
432021
Differential biological activity of disease-associated JAK2 mutants
H Zou, D Yan, G Mohi
FEBS letters 585 (7), 1007-1013, 2011
372011
Novel halophyte EREBP/AP2_type DNA binding protein improves salt tolerance in transgenic tobacco
S Yi-Guo, YAN Dong-Qing, Z Wan-Ke, DU Bao-Xin, Z Jin-Song, LIU Qiang, ...
Journal of Integrative Plant Biology 45 (1), 82, 2003
372003
The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations
A Franzini, AD Pomicter, D Yan, JS Khorashad, SK Tantravahi, H Than, ...
Blood Advances 3 (20), 2949-2961, 2019
332019
Nuclear–cytoplasmic transport is a therapeutic target in myelofibrosis
D Yan, AD Pomicter, S Tantravahi, CC Mason, AV Senina, JM Ahmann, ...
Clinical Cancer Research 25 (7), 2323-2335, 2019
332019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera
AB Patel, A Franzini, E Leroy, SJ Kim, AD Pomicter, L Genet, M Xiao, ...
Blood, The Journal of the American Society of Hematology 134 (26), 2388-2398, 2019
312019
Overexpression of proline transporter gene isolated from halophyte confers salt tolerance in Arabidopsis
S Yi-Guo, Z Wan-Ke, YAN Dong-Qing, DU Bao-Xing, Z Jin-Song, ...
Journal of Integrative Plant Biology 44 (8), 956, 2002
282002
STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice
A Dutta, D Yan, RE Hutchison, G Mohi
British journal of haematology 180 (6), 911, 2018
212018
Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice
D Yan, F Jobe, RE Hutchison, G Mohi
Leukemia 29 (10), 2050-2061, 2015
202015
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis
H Zhao, AD Pomicter, AM Eiring, A Franzini, J Ahmann, JY Hwang, ...
Blood, The Journal of the American Society of Hematology 139 (5), 761-778, 2022
112022
Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia
MS Zabriskie, CA Eide, D Yan, NA Vellore, AD Pomicter, SL Savage, ...
Leukemia 30 (6), 1418-1421, 2016
112016
Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice
D Yan, RE Hutchison, G Mohi
Blood, The Journal of the American Society of Hematology 120 (9), 1888-1898, 2012
112012
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
H Than, AD Pomicter, D Yan, LP Beaver, AM Eiring, WL Heaton, A Senina, ...
Leukemia 34 (6), 1679-1683, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20